Cargando…

En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene

En coup de sabre (ECDS) is a form of linear scleroderma or morphea that distinctly appears on the forehead and/or frontoparietal scalp. We report a case of a 6-year-old female that presented with a linear, hyperpigmented scar on her left forehead extending to her scalp with resultant alopecia and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Coican, Alexis, Giansiracusa, Derrek M, Greenfield, Melinda F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404129/
https://www.ncbi.nlm.nih.gov/pubmed/37546139
http://dx.doi.org/10.7759/cureus.41459
_version_ 1785085228458442752
author Coican, Alexis
Giansiracusa, Derrek M
Greenfield, Melinda F
author_facet Coican, Alexis
Giansiracusa, Derrek M
Greenfield, Melinda F
author_sort Coican, Alexis
collection PubMed
description En coup de sabre (ECDS) is a form of linear scleroderma or morphea that distinctly appears on the forehead and/or frontoparietal scalp. We report a case of a 6-year-old female that presented with a linear, hyperpigmented scar on her left forehead extending to her scalp with resultant alopecia and discoloration in the affected area. The patient was subsequently treated with topical calcipotriene ointment and had an excellent response with normalization of the sclerotic skin, hair regrowth, and improved hyperpigmentation. This report demonstrates that a conservative approach to treating pediatric patients with ECDS via calcipotriene ointment can be safe and effective.
format Online
Article
Text
id pubmed-10404129
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-104041292023-08-06 En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene Coican, Alexis Giansiracusa, Derrek M Greenfield, Melinda F Cureus Dermatology En coup de sabre (ECDS) is a form of linear scleroderma or morphea that distinctly appears on the forehead and/or frontoparietal scalp. We report a case of a 6-year-old female that presented with a linear, hyperpigmented scar on her left forehead extending to her scalp with resultant alopecia and discoloration in the affected area. The patient was subsequently treated with topical calcipotriene ointment and had an excellent response with normalization of the sclerotic skin, hair regrowth, and improved hyperpigmentation. This report demonstrates that a conservative approach to treating pediatric patients with ECDS via calcipotriene ointment can be safe and effective. Cureus 2023-07-06 /pmc/articles/PMC10404129/ /pubmed/37546139 http://dx.doi.org/10.7759/cureus.41459 Text en Copyright © 2023, Coican et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Coican, Alexis
Giansiracusa, Derrek M
Greenfield, Melinda F
En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
title En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
title_full En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
title_fullStr En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
title_full_unstemmed En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
title_short En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
title_sort en coup de sabre in a pediatric patient treated with calcipotriene
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404129/
https://www.ncbi.nlm.nih.gov/pubmed/37546139
http://dx.doi.org/10.7759/cureus.41459
work_keys_str_mv AT coicanalexis encoupdesabreinapediatricpatienttreatedwithcalcipotriene
AT giansiracusaderrekm encoupdesabreinapediatricpatienttreatedwithcalcipotriene
AT greenfieldmelindaf encoupdesabreinapediatricpatienttreatedwithcalcipotriene